153 related articles for article (PubMed ID: 35838554)
21. The role of human papillomavirus in p16-positive oral cancers.
Belobrov S; Cornall AM; Young RJ; Koo K; Angel C; Wiesenfeld D; Rischin D; Garland SM; McCullough M
J Oral Pathol Med; 2018 Jan; 47(1):18-24. PubMed ID: 29024035
[TBL] [Abstract][Full Text] [Related]
22. Prevalence and types of high-risk human papillomaviruses in head and neck cancers from Bangladesh.
Shaikh MH; Khan AI; Sadat A; Chowdhury AH; Jinnah SA; Gopalan V; Lam AK; Clarke DTW; McMillan NAJ; Johnson NW
BMC Cancer; 2017 Nov; 17(1):792. PubMed ID: 29178862
[TBL] [Abstract][Full Text] [Related]
23. Role of human papillomavirus in non-oropharyngeal head and neck cancers.
Combes JD; Franceschi S
Oral Oncol; 2014 May; 50(5):370-9. PubMed ID: 24331868
[TBL] [Abstract][Full Text] [Related]
24. The Isothermal Amplification AmpFire Assay for Human Papillomavirus (HPV) Detection and Genotyping in Formalin-Fixed, Paraffin-Embedded Oropharyngeal Cancer Samples.
Paytubi S; Taberna M; Mena M; Quirós B; Gomà M; Alemany L; Bosch FX; Pavón MÁ
J Mol Diagn; 2022 Jan; 24(1):79-87. PubMed ID: 34801703
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of Diagnostic Utility of a High-Risk Human Papillomavirus PCR Test on Formalin-Fixed, Paraffin-Embedded Head and Neck Tumor Tissues.
Huho AN; Yadak N; Bocklage TJ; Yang S
J Mol Diagn; 2018 Mar; 20(2):232-239. PubMed ID: 29277636
[TBL] [Abstract][Full Text] [Related]
26. Salivary High-Risk Human Papillomavirus (HPV) DNA as a Biomarker for HPV-Driven Head and Neck Cancers.
Ekanayake Weeramange C; Liu Z; Hartel G; Li Y; Vasani S; Langton-Lockton J; Kenny L; Morris L; Frazer I; Tang KD; Punyadeera C
J Mol Diagn; 2021 Oct; 23(10):1334-1342. PubMed ID: 34325059
[TBL] [Abstract][Full Text] [Related]
27. Detection of active human papilloma virus-16 in head and neck cancers of Asian North Indian patients.
Sannigrahi MK; Singh V; Sharma R; Panda NK; Radotra BD; Khullar M
Oral Dis; 2016 Jan; 22(1):62-8. PubMed ID: 26475514
[TBL] [Abstract][Full Text] [Related]
28. Esophageal squamous cell cancer in patients with head and neck cancer: Prevalence of human papillomavirus DNA sequences.
de Villiers EM; Gunst K; Stein H; Scherübl H
Int J Cancer; 2004 Mar; 109(2):253-8. PubMed ID: 14750177
[TBL] [Abstract][Full Text] [Related]
29. Human Papillomavirus Detected in Oropharyngeal Cancers from Chilean Subjects.
Oliva C; Carrillo-Beltrán D; Boettiger P; Gallegos I; Aguayo F
Viruses; 2022 Jun; 14(6):. PubMed ID: 35746684
[TBL] [Abstract][Full Text] [Related]
30. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers.
Gillison ML; D'Souza G; Westra W; Sugar E; Xiao W; Begum S; Viscidi R
J Natl Cancer Inst; 2008 Mar; 100(6):407-20. PubMed ID: 18334711
[TBL] [Abstract][Full Text] [Related]
31. The distribution of human papillomavirus in tissues from patients with head and neck squamous cell carcinoma.
Wei W; Shi Q; Guo F; Zhang BY; Chen C; Zhang NS; Dong XP
Oncol Rep; 2012 Nov; 28(5):1750-6. PubMed ID: 22923266
[TBL] [Abstract][Full Text] [Related]
32. Validation of methods for oropharyngeal cancer HPV status determination in US cooperative group trials.
Jordan RC; Lingen MW; Perez-Ordonez B; He X; Pickard R; Koluder M; Jiang B; Wakely P; Xiao W; Gillison ML
Am J Surg Pathol; 2012 Jul; 36(7):945-54. PubMed ID: 22743284
[TBL] [Abstract][Full Text] [Related]
33. Attenuated TRAF3 Fosters Activation of Alternative NF-κB and Reduced Expression of Antiviral Interferon, TP53, and RB to Promote HPV-Positive Head and Neck Cancers.
Zhang J; Chen T; Yang X; Cheng H; Späth SS; Clavijo PE; Chen J; Silvin C; Issaeva N; Su X; Yarbrough WG; Annunziata CM; Chen Z; Van Waes C
Cancer Res; 2018 Aug; 78(16):4613-4626. PubMed ID: 29921694
[TBL] [Abstract][Full Text] [Related]
34. Human papillomavirus (HPV) in head and neck cancer. An association of HPV 16 with squamous cell carcinoma of Waldeyer's tonsillar ring.
Paz IB; Cook N; Odom-Maryon T; Xie Y; Wilczynski SP
Cancer; 1997 Feb; 79(3):595-604. PubMed ID: 9028373
[TBL] [Abstract][Full Text] [Related]
35. Human papillomavirus seropositivity and risks of head and neck cancer.
Smith EM; Ritchie JM; Pawlita M; Rubenstein LM; Haugen TH; Turek LP; Hamsikova E
Int J Cancer; 2007 Feb; 120(4):825-32. PubMed ID: 17131312
[TBL] [Abstract][Full Text] [Related]
36. Examining the incidence of human papillomavirus-associated head and neck cancers by race and ethnicity in the U.S., 1995-2005.
Cole L; Polfus L; Peters ES
PLoS One; 2012; 7(3):e32657. PubMed ID: 22448226
[TBL] [Abstract][Full Text] [Related]
37. Does pretreatment seropositivity to human papillomavirus have prognostic significance for head and neck cancers?
Smith EM; Rubenstein LM; Ritchie JM; Lee JH; Haugen TH; Hamsikova E; Turek LP
Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):2087-96. PubMed ID: 18708401
[TBL] [Abstract][Full Text] [Related]
38. Zinc finger A20 and NF-κB correlate with high-risk human papillomavirus of squamous cell carcinoma patients.
Tang YJ; Khalaf AT; Liu XM; Xu CX; Zhao W; Cheng S; Zhang RZ
Tumour Biol; 2014 Dec; 35(12):11855-60. PubMed ID: 25230785
[TBL] [Abstract][Full Text] [Related]
39. Human papillomavirus status in young patients with head and neck squamous cell carcinoma.
van Monsjou HS; van Velthuysen ML; van den Brekel MW; Jordanova ES; Melief CJ; Balm AJ
Int J Cancer; 2012 Apr; 130(8):1806-12. PubMed ID: 21607949
[TBL] [Abstract][Full Text] [Related]
40. Fundamental differences in cell cycle deregulation in human papillomavirus-positive and human papillomavirus-negative head/neck and cervical cancers.
Pyeon D; Newton MA; Lambert PF; den Boon JA; Sengupta S; Marsit CJ; Woodworth CD; Connor JP; Haugen TH; Smith EM; Kelsey KT; Turek LP; Ahlquist P
Cancer Res; 2007 May; 67(10):4605-19. PubMed ID: 17510386
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
